CNTB - Connect Biopharma Holdings Limited Ordinary Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.79 0.08 (4.47%) --- --- --- --- 0.08 (4.47%) --- ---

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.19
Diluted EPS:
-0.19
Basic P/E:
-9.8421
Diluted P/E:
-9.8421
RSI(14) 1m:
66.67
VWAP:
1.87
RVol:
0.6994

Events

Period Kind Movement Occurred At
1m Price increase 1m 1.83 +0.04 (+2.23%) Oct 15 09:30

Related News